Cash & equivalents increased 31.4%
Cash & equivalents changed +31.4% from the comparable as-filed period. The change ranks at the 71th percentile of 239 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +31.4% from the comparable as-filed period. The change ranks at the 71th percentile of 239 prior comparable changes.
Debt changed +100.8% from the comparable as-filed period. The change ranks at the 93th percentile of 74 prior comparable changes.
Net income changed +30.5% from the comparable as-filed period. The change ranks at the 73th percentile of 135 prior comparable changes.
Operating income changed +38.1% from the comparable as-filed period. The change ranks at the 84th percentile of 135 prior comparable changes.
Operating margin changed +485 basis points from the comparable as-filed period. The change ranks at the 73th percentile of 135 prior comparable changes.
Revenue changed +25.7% from the comparable as-filed period. The change ranks at the 99th percentile of 135 prior comparable changes.
Selling, general & administrative changed +22.8% from the comparable as-filed period. The change ranks at the 100th percentile of 135 prior comparable changes.
Stock-based compensation changed +24.8% from the comparable as-filed period. The change ranks at the 73th percentile of 131 prior comparable changes.
Research & development changed +13.8% from the comparable as-filed period. The change ranks at the 57th percentile of 135 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.